Status:
COMPLETED
HPVPro Study: Comparison of HPV Detection in Clinician-collected Cervical Swabs and Self-sampled Cervicovaginal Swabs
Lead Sponsor:
The Institute of Molecular and Translational Medicine, Czech Republic
Collaborating Sponsors:
National Institute for Cancer Research, Czech Republic
Conditions:
Cervical Cancer
Cervical Dysplasia
Eligibility:
FEMALE
30-64 years
Phase:
NA
Brief Summary
Comparison of the detection of human papillomavirus DNA in paired physician-obtained cervical swabs and self-sampled cervicovaginal swabs and evaluation of HPV prevalence in Czech women screening popu...
Detailed Description
The cervical screening program in the Czech Republic is based on cytology with HPV triage. Nevertheless, cytology-based cervical screening may switch to HPV-based cervical screening in future. The imp...
Eligibility Criteria
Inclusion
- Women with age 30-64 years.
- Women attending cervical cancer screening program in Czech Republic.
- Women with completed informed consent.
Exclusion
- Pregnant women.
- Women with no sexual intercourse experience.
- Women after cervical conization or hysterectomy.
- Women with CIN or cervical carcinoma in anamnesis.
- Women at risk of increased bleeding.
Key Trial Info
Start Date :
September 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 25 2019
Estimated Enrollment :
1044 Patients enrolled
Trial Details
Trial ID
NCT04133610
Start Date
September 1 2018
End Date
November 25 2019
Last Update
November 26 2019
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
GYN-PREN, Ltd.
Frýdek-Místek, Czechia
2
GYNPRENATAL, Ltd.
Havířov, Czechia
3
MEDIOL, Ltd.
Olomouc, Czechia